Literature DB >> 16936731

Transcription factors TFE3 and TFEB are critical for CD40 ligand expression and thymus-dependent humoral immunity.

Chongmin Huan1, Matthew L Kelly, Ryan Steele, Iuliana Shapira, Susan R S Gottesman, Christopher A J Roman.   

Abstract

TFE3 and TFEB are broadly expressed transcription factors related to the transcription factor Mitf. Although they have been linked to cytokine signaling pathways in nonlymphoid cells, their function in T cells is unknown. TFE3-deficient mice are phenotypically normal, whereas TFEB deficiency causes early embryonic death. We now show that combined inactivation of TFE3 and TFEB in T cells resulted in a hyper-immunoglobulin M syndrome due to impaired expression of CD40 ligand by CD4(+) T cells. Native TFE3 and TFEB bound to multiple cognate sites in the promoter of the gene encoding CD40 ligand (Cd40lg), and maximum Cd40lg promoter activity and gene expression required TFE3 or TFEB. Thus, TFE3 and TFEB are direct, physiological and mutually redundant activators of Cd40lg expression in activated CD4(+) T cells critical for T cell-dependent antibody responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16936731      PMCID: PMC2386253          DOI: 10.1038/ni1378

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  54 in total

1.  Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2.

Authors:  H Lindgren; K Axcrona; T Leanderson
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

2.  Microphthalmia: a signal responsive transcriptional regulator in development.

Authors:  D E Fisher
Journal:  Pigment Cell Res       Date:  2000

3.  NFATc1 and NFATc2 together control both T and B cell activation and differentiation.

Authors:  S L Peng; A J Gerth; A M Ranger; L H Glimcher
Journal:  Immunity       Date:  2001-01       Impact factor: 31.745

Review 4.  Control of lymphocyte development by nuclear factor-kappaB.

Authors:  Ulrich Siebenlist; Keith Brown; Estefania Claudio
Journal:  Nat Rev Immunol       Date:  2005-06       Impact factor: 53.106

5.  Microphthalmic mice display a B cell deficiency similar to that seen for mast and NK cells.

Authors:  K Roundy; A Kollhoff; E J Eichwald; J J Weis; J H Weis
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

Review 6.  MITF: a stream flowing for pigment cells.

Authors:  M Tachibana
Journal:  Pigment Cell Res       Date:  2000-08

Review 7.  CD40 ligand in CLL pathogenesis and therapy.

Authors:  E J Schattner
Journal:  Leuk Lymphoma       Date:  2000-05

8.  Transcriptional activity of the distal CD40 ligand promoter.

Authors:  F M Lobo; S Xu; C Lee; R L Fuleihan
Journal:  Biochem Biophys Res Commun       Date:  2000-12-09       Impact factor: 3.575

9.  Regulatory defects in Cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells.

Authors:  Y Yi; M McNerney; S K Datta
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

10.  Identification of a CD28 response element in the CD40 ligand promoter.

Authors:  E Parra; T Mustelin; M Dohlsten; D Mercola
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

View more
  34 in total

1.  Embryonic expression of zebrafish MiT family genes tfe3b, tfeb, and tfec.

Authors:  James A Lister; Brandon M Lane; Anhthu Nguyen; Katherine Lunney
Journal:  Dev Dyn       Date:  2011-09-19       Impact factor: 3.780

2.  Transcriptional factor EB regulates macrophage polarization in the tumor microenvironment.

Authors:  Liang Fang; Johnie Hodge; Fatma Saaoud; Junfeng Wang; Stephen Iwanowycz; Yuzhen Wang; Yvonne Hui; Trent D Evans; Babak Razani; Daping Fan
Journal:  Oncoimmunology       Date:  2017-04-20       Impact factor: 8.110

Review 3.  Emerging roles for TFEB in the immune response and inflammation.

Authors:  Owen A Brady; José A Martina; Rosa Puertollano
Journal:  Autophagy       Date:  2017-07-24       Impact factor: 16.016

4.  TRIM37 deficiency induces autophagy through deregulating the MTORC1-TFEB axis.

Authors:  Wei Wang; Zhijie Xia; Jean-Claude Farré; Suresh Subramani
Journal:  Autophagy       Date:  2018-08-21       Impact factor: 16.016

5.  TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophages.

Authors:  Nunzia Pastore; Owen A Brady; Heba I Diab; José A Martina; Lu Sun; Tuong Huynh; Jeong-A Lim; Hossein Zare; Nina Raben; Andrea Ballabio; Rosa Puertollano
Journal:  Autophagy       Date:  2016-05-12       Impact factor: 16.016

6.  The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris.

Authors:  José A Martina; Heba I Diab; Li Lishu; Lim Jeong-A; Simona Patange; Nina Raben; Rosa Puertollano
Journal:  Sci Signal       Date:  2014-01-21       Impact factor: 8.192

Review 7.  Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.

Authors:  Eric C Kauffman; Christopher J Ricketts; Soroush Rais-Bahrami; Youfeng Yang; Maria J Merino; Donald P Bottaro; Ramaprasad Srinivasan; W Marston Linehan
Journal:  Nat Rev Urol       Date:  2014-07-22       Impact factor: 14.432

Review 8.  Oncogenic gene fusions in epithelial carcinomas.

Authors:  John R Prensner; Arul M Chinnaiyan
Journal:  Curr Opin Genet Dev       Date:  2009-02-21       Impact factor: 5.578

Review 9.  TFEB and TFE3: Linking Lysosomes to Cellular Adaptation to Stress.

Authors:  Nina Raben; Rosa Puertollano
Journal:  Annu Rev Cell Dev Biol       Date:  2016-06-01       Impact factor: 13.827

10.  Functional analysis of a tripartite stability element within the CD40 ligand 3' untranslated region.

Authors:  Jennifer Laughlin; Sanaz Oghlidos; Joseph F Porter; Rodrigo Matus-Nicodemos; Frank L Sinquett; Valentina Marcelli; Lori R Covey
Journal:  Immunology       Date:  2008-01-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.